[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356711-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356711-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-imaging-in-gastric-cancer-state-of-the-art-techniques-and-emerging-opportunities","Molecular imaging in gastric cancer - state-of-the-art techniques and emerging opportunities","","Gastric cancer remains a major global health challenge, with poor survival driven by late-stage diagnosis and the limitations of conventional imaging such as CT, MRI, and FDG PET/CT for early lesion detection, peritoneal metastasis identification, and tumor heterogeneity characterization. The review highlights the need for non-invasive molecular imaging that visualizes GC-specific biomarkers to improve diagnosis, risk stratification, and personalized therapy planning. It covers recent platforms including PET, SPECT, optical imaging, and molecular MRI, alongside probe development and clinical translation challenges.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-imaging-in-gastric-cancer-state-of-the-art-techniques-and-emerging-opportunities/356711/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-imaging-in-gastric-cancer-state-of-the-art-techniques-and-emerging-opportunities/356711.png","ImageObject",300,407,{"name":42,"@type":43},"Fahsai","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is molecular imaging needed in gastric cancer?","Question",{"text":63,"@type":64},"Conventional imaging modalities often lack sensitivity for early lesions, struggle with detecting peritoneal metastases, and cannot adequately capture tumor heterogeneity, leading to late diagnosis and limited risk stratification. Non-invasive imaging of GC-specific molecular biomarkers is presented as a key unmet need.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which molecular imaging techniques are covered in the review?",{"text":68,"@type":64},"The review summarizes advances across PET, SPECT, molecular optical imaging, and molecular MRI. It explains how tracer-based high sensitivity combined with high-resolution anatomical imaging enables in vivo visualization of molecular targets and biological processes.",{"name":70,"@type":61,"acceptedAnswer":71},"What probe types and targets are emphasized?",{"text":72,"@type":64},"It discusses development of probes including monoclonal antibodies, single-domain antibodies, affibodies, peptides, and nanomaterials. Representative molecular targets mentioned include HER2, PD-L1, CLDN18.2, FAP, VEGF, and Trop2.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356711,1790178475,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Lan etal. Journal of Translational Medicine (2026) 24:616  \n[https://doi.org/10.1186/s12967-026-08011-6](https://doi.org/10.1186/s12967-026-08011-6)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nMolecular imaging in gastric cancer: stateof-the-art techniques and emerging opportunities  \nKexin Lan 1†, Yongshun Liu2†, Ruobing Li3, Zhaonan Sun2* and Wenpeng Huang4*  \nAbstract  \nBackground Gastric cancer (GC) remains a major global health challenge with persistently poor survival rates, largely attributable to late-stage diagnosis and the inherent limitations of conventional imaging modalities, including CT, MRI, and FDG PET/CT, in detecting early lesions, identifying peritoneal metastases, and capturing tumor heterogeneity. There is a critical unmet need for non-invasive imaging approaches capable of visualizing GC-specific molecular biomarkers to enable more accurate diagnosis, risk stratification, and personalized treatment planning. Main body Molecular imaging integrates high-sensitivity tracer-based techniques with high-resolution anatomical imaging, allowing in vivo visualization of key biological processes and molecular targets in GC. This review provides a comprehensive overview of recent advances in molecular imaging platforms for GC, including PET, SPECT, molecular optical imaging, and molecular MRI. We summarize the biological rationale, imaging mechanisms, and emerging clinical relevance of representative molecular targets, such as HER2, PD-L1, CLDN18 . 2, FAP, VEGF, and Trop2 . In addition, we discuss the development and application of diverse classes of imaging probes, including monoclonal antibodies, single-domain antibodies, affibodies, peptides, and nanomaterials, highlighting their roles in improving lesion detection, delineating intratumoral heterogeneity, guiding targeted and immune-based therapies, and supporting image-guided surgical and interventional procedures. Key challenges in clinical translation, including dynamic target expression, suboptimal pharmacokinetics, and the lack of standardized imaging protocols, are also critically examined.  \nConclusions Despite existing translational barriers, continued advances in probe engineering, chemical synthesis, and imaging instrumentation are rapidly expanding the clinical potential of molecular imaging in GC. These developments are expected to facilitate more precise diagnosis, treatment monitoring, and patient stratification, ultimately supporting the broader goals of precision oncology and personalized management of gastric cancer. Keywords Gastric cancer, Molecular imaging, ImmunoPET, HER2, PD-L1, CLDN18 .2  \n†Kexin Lan and Yongshun Liu contributed equally to this work.  \n*Correspondence:  \nZhaonan Sun [zhaonan_sun@163.com](zhaonan_sun@163.com)[ ](zhaonan_sun@163.com)Wenpeng Huang [hwpeng19950930@163.com](hwpeng19950930@163.com)  \n1Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China  \n2Department of Medical Imaging, Peking University First Hospital, Beijing 100034, China  \n3College of Letters and Science, University of Wisconsin – Madison, Madison, WI 53705, USA  \n4Department of Radiology, Geriatric Hospital of Nanjing Medical University (Jiangsu Province Official Hospital), Nanjing 210024, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If ","cbCaidtki0YZUpxy","https://ap.wps.com/l/cbCaidtki0YZUpxy","pdf",3695078,27,"English","# Abstract\n# Introduction\n# Molecular imaging platform overview\n# Clinical translation challenges\n# Conclusions\n# Keywords","[{\"question\":\"Why is molecular imaging needed in gastric cancer?\",\"answer\":\"Conventional imaging modalities often lack sensitivity for early lesions, struggle with detecting peritoneal metastases, and cannot adequately capture tumor heterogeneity, leading to late diagnosis and limited risk stratification. Non-invasive imaging of GC-specific molecular biomarkers is presented as a key unmet need.\"},{\"question\":\"Which molecular imaging techniques are covered in the review?\",\"answer\":\"The review summarizes advances across PET, SPECT, molecular optical imaging, and molecular MRI. It explains how tracer-based high sensitivity combined with high-resolution anatomical imaging enables in vivo visualization of molecular targets and biological processes.\"},{\"question\":\"What probe types and targets are emphasized?\",\"answer\":\"It discusses development of probes including monoclonal antibodies, single-domain antibodies, affibodies, peptides, and nanomaterials. Representative molecular targets mentioned include HER2, PD-L1, CLDN18.2, FAP, VEGF, and Trop2.\"}]","Molecular imaging in gastric cancer - state-of-the-art techniques and emerging opportunities | PDF",1790126898,68,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fcf98a351d21a3661641d02bfed0dc3.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24e44dbdceac6100c1442f2319b77e66.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fab6a33f55274f382d3f175edd5e120.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c51bef4d8fd8a050ab85f10bddbe2eb9.webp",980,1306]